Skip to main content

Table 2 Baseline characteristics by eGFR and co-managed status

From: Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study

 

Pre-eGFR/ PCP

managed (n = 222)

Post-eGFR/ PCP

managed (n = 159)

P-Value* (PCP managed,

Pre vs. Post)

Pre-eGFR/

Co-managed (n = 52)

Post-eGFR/

Co-managed (n = 107)

P-Value* (Co- managed,

Pre vs. Post)

Age (years)

72.2 (12.5)†

69.6 (13.0)

0.05

63.3 (16.1)†

67.3 (14.0)

0.11

Female

72.1% (160)

62.9% (100)

0.06

65.4% (34)

57.9% (62)

0.37

African-American

22.5% (50)

36.5% (58)

0.0005

28.9% (15)

41.1% (44)

0.13

Diabetes

30.2% (67)

34.0% (54)

0.25

38.5% (20)

41.1% (44)

0.75

Hypertension

64.4% (143)

75.5% (120)

0.02

57.7% (30)

86.0% (92)

< 0.0001

Insurance Status

      

   Private

30.6% (68)

45.3% (72)

0.009

40.4% (21)

48.6% (52)

0.67

   Medicare

59.0% (131)

49.1% (78)

 

46.2% (24)

41.1% (44)

 

   Medical Assistance

5.0% (11)

4.4% (7)

 

7.7% (4)

7.5% (8)

 

   Self-pay

5.4% (12)

1.3% (2)

 

5.8% (3)

2.8% (3)

 

eGFR

(ml/min/1.73 m2)

37.2 (6.3)**

35.5 (7.5)‡

0.02

31.4 (8.2)**

31.0 (7.6)‡

0.78

Creatinine (mg/dl)

1.71 (0.42)**

1.83 (0.56)‡

0.02

2.18 (0.71)**

2.19 (0.86)‡

0.94

  1. Continuous variables are presented as means with standard deviations. Categorical variables are expressed as percentages and frequencies.
  2. *Students t-test, chi-square, or Fisher's exact test used as appropriate.
  3. †pre-eGFR PCP managed versus pre-eGFR co-managed (P = 0.0004)
  4. **pre-eGFR PCP managed versus pre-eGFR co-managed (P < 0.0001)
  5. ‡post-eGFR PCP managed versus post-eGFR co-managed (P < 0.0001)
  6. eGFR estimated glomerular filtration rate, PCP primary care physician.